Jack Lin analyst MORGAN STANLEY

Currently out of the existing stock ratings of Jack Lin, 3 are a BUY (75%), 1 are a HOLD (25%).

Jack Lin

Work Performance Price Targets & Ratings Chart

Analyst Jack Lin, currently employed at MORGAN STANLEY, has had 50% of price targets met with an average potential upside of 8.93%, reached in 29 days on average.

Jack Lin has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HCM, HUTCHMED DRC at 22-Sep-2025.

Wall Street Analyst Jack Lin

Analyst best performing recommendations are on HCM (HUTCHMED DRC).
The best stock recommendation documented was for HCM (HUTCHMED DRC) on 5/14/2024. The price target of $17.5 was fulfilled within 37 days with a profit of $3.9 (18.22%), with a performance score of 4.93.

Average potential price target upside

HCM HUTCHMED DRC ZLAB Zai Lab Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Nov-2023

$14

$-0.9 (-6.04%)

$16

3 months 28 days ago
(23-Jul-2026)

6/9 (66.67%)

$3.04 (27.74%)

151

Buy Since 23-Oct-2019

$17

$2.1 (14.09%)

$27

4 months 13 days ago
(07-Jul-2026)

1/3 (33.33%)

$5.92 (53.43%)

85

Buy Since 10-Mar-2026

$20

$5.1 (34.23%)

$28

8 months 10 days ago
(10-Mar-2026)

0/2 (0%)

$6.11 (43.99%)

Hold Since 22-Sep-2025

$13.75

$17.5

1 years 1 months 29 days ago
(22-Sep-2025)

2/2 (100%)

$-2.91 (-17.47%)

58

Buy Since 12-Mar-2020

$50

$50

3 years 2 months 15 days ago
(05-Sep-2023)

1/6 (16.67%)

$35.15 (236.70%)

477

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Jack Lin?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?